Targeting Slit-Roundabout signaling inhibits tumor angiogenesis in chemical-induced squamous cell carcinogenesis
Authors: Wang, Li-Jing; Zhao, Yuan1; Han, Bing2; Ma, Yu-Guang1; Zhang, Jie1; Yang, Ding-Ming3; Mao, Jian-Wen4; Tang, Fu-Tian4; Li, Wei-Dong4; Yang, Yang4; Wang, Rui; Geng, Jian-Guo
Source: Cancer Science, Volume 99, Number 3, March 2008 , pp. 510-517(8)
Publisher: Blackwell Publishing
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
Slit is a secreted protein known to function through the Roundabout (Robo) receptor as a repellent for axon guidance and neuronal migration, and as an inhibitor in leukocyte chemotaxis. We have previously shown that Slit2 is also secreted by a variety of human cancer cells whereby it acts as a chemoattractant to vascular endothelial cells for tumor angiogenesis. We used a blocking antibody to investigate the role of Slit-Robo signaling in tumor angiogenesis during oral carcinogenesis. In this report we undertook a multistage model of 7,12-dimethyl-1,2-benzanthracene-induced squamous cell carcinoma in the hamster buccal pouch. R5, a monoclonal antibody against the first immunoglobulin domain of Robo1, was used to study whether R5 blocks the Slit-Robo interaction and furthermore inhibits tumor angiogenesis and growth in our model. In addition, the expression of Slit2, von Willebrand factor, and vascular endothelial growth factor were examined using human tissue of oral cheek mucosa with oral squamous cell carcinoma. Our data showed that Slit2 was expressed minimally in normal and hyperplastic mucosa, moderately in dysplastic mucosa, and highly in neoplastic mucosa obtained from hamster buccal pouch. We also found that increased Slit2 expression was associated with higher tumor angiogenesis, as reflected by increased vascular endothelial growth factor expression and microvessel density. A similar Slit2 expression profile was found in human tissue. Importantly, interruption of the Slit2-Robo interaction using R5 inhibited tumor angiogenesis and growth in our in vivo model, which indicates that Slit2-mediated tumor angiogenesis is a critical process underlying the carcinogenesis of chemical-induced squamous cell carcinoma. Therefore, targeting Slit-Robo signaling may offer a novel antiangiogenesis approach for oral cancer therapy. (Cancer Sci 2008; 99: 510-517)Document Type: Research article
DOI: 10.1111/j.1349-7006.2007.00721.x
Affiliations: 1: Department of Biochemistry and Molecular Biology, Schools of Life Sciences, School of Stomatology, Lanzhou University, Lanzhou 730000; 2: Medical College of North-west for Nationalities, Lanzhou 730030, China; 3: Shiel Medical Diagnostic Laboratory, Brooklyn, NY 11205, USA 4: Institute of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China;
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Click here for Page Help